China given access to UK patients' health data
Chinese researchers will be granted access to NHS data despite MI5 fears that Beijing's regime could acquire sensitive information, an investigation has found.
UK Biobank, a research hub, is preparing to transfer data from half a million GP records to its central database where it will be available for use by universities, scientific institutes and private companies.
The medical information has been donated by volunteers, who have agreed for data from their GP records to be added to the database.
Health officials have now audited processes for sharing data internationally – including assessment of applications from China.
A spokesman from UK Biobank told The Guardian that China had passed the audit, meaning researchers from the country can apply to access the records.
The newspaper's analysis found that one in five successful applications for access to medical data already held by UK Biobank has come from China.
MI5 has previously warned that Chinese organisations and individuals granted access to UK data could be ordered by Chinese intelligence agencies to carry out work on their behalf.
In a joint address in July 2022, Ken McCallum, MI5's director general, and Christopher Wray, the then FBI director, raised concerns about Chinese entities attempting to acquire sensitive information and technology from Western institutions, warning of businesses and individuals being 'forced by law' to co-operate with the Chinese Communist Party.
For the past year, UK health officials had been assessing whether extra safeguards were needed for patient records when added to the genomes, tissue samples and questionnaire responses in the database.
Personal details such as names and dates of birth are stripped from the database before it is shared, but some experts say it is possible for some individuals to be identified.
Luke de Pulford, executive director of the Inter-Parliamentary Alliance on China, said: 'UK data transfer rules are totally inadequate. Zettabytes of personal data are routinely transferred to China, and it's all totally legal.
'Beijing's regulations make enforcing data rights in Xi's party-state impossible, and vulnerable to requisition by the Chinese authorities. We should close the loophole that allows UK citizens to be exposed to this.'
A government spokesman said 'Security and privacy considerations are always taken into account when UK health data is used to drive forward our understanding of diseases and advance scientific research.' Health data was 'only shared with legitimate researchers', he added.
Of the 1,375 successful applications for access to UK Biobank data, 265 came from China, second only to the US, according to a Guardian analysis of its published records.
A unit of Chinese genetics company BGI is among those given approval to access the data.
The US has blacklisted BGI subsidiaries. In 2023, Joe Biden's government justified the restrictions, saying it had information indicating that BGI units' 'collection and analysis of genetic data poses a significant risk of contributing to monitoring and surveillance by the government of China, which has been utilised in the repression of ethnic minorities in China'.
It also claimed 'the actions of these entities concerning the collection and analysis of genetic data present a significant risk of diversion to China's military programs'.
But a BGI representative said these were 'unsubstantiated allegations', adding: 'We have never undertaken genetic surveillance of anybody. BGI does not engage in unethical practices and does not provide gene technology for surveillance. BGI does not condone and would never be involved in any human rights abuses.'
The company dismissed claims the military could access data, saying its research 'is undertaken for civilian and scientific purposes only'.
A UK Biobank representative said it was 'continually in dialogue' with MI5 and other state agencies about the use of its data, including by BGI.
Chinese researchers have used UK Biobank data to research air pollution and biological markers to predict dementia.
In October, Wes Streeting, the health secretary, gave instructions to press ahead with the transfer of patient records for consenting volunteers to UK Biobank and other research hubs, despite objections from some GPs and privacy campaigners.
In December, Michael Chapman, a senior NHS England official, said 'access will only be for countries approved by NHS England', adding that approval would be based on 'security considerations' and countries' data protection.
NHS England said: 'Any approval of access to personal data from overseas territories requires data recipients to comply with their responsibilities' under UK data law 'and is kept under review if circumstances change'.
Intelligence sources raised concerns that health data can be useful in espionage if anonymisation can be broken. Experts say it may be possible to match public information about an individual's medical treatment with anonymised patient records to identify who they refer to.
Edward You, then a top US intelligence officer specialising in new technologies, said in 2021. 'Once they have access to your genetic data, it's not something you can change like a pin code.'
A spokesman for UK Biobank said it had 'no evidence of anyone being identified'.
Prof Sir Rory Collins, UK Biobank's chief executive, said: 'All our volunteers have given explicit consent for researchers to study their de-identified health data, and many have emphasised the importance of their GP data being analysed.'
After China adopted legislation in 2017 to enforce cooperation with the regime's spies, MI5 warned custodians of British personal data that the national intelligence law 'may affect the level of control you have over your information and assets as you engage with Chinese individuals and organisations, especially if you work in an area that is of interest to the Chinese state'.
Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
44 minutes ago
- Yahoo
FTSE 100 LIVE: Markets slide as China accuses US of violating trade deal
The FTSE 100 (^FTSE) and European stocks slipped on Monday as China said the US "severely violated" the terms of their recent trade truce. Chinese officials said they would take strong measures to defend the country's interests. The two countries recently agreed to a 90-day moratorium after talks in Geneva, pledging to lower the tariffs on each other's goods. The US lowered its levy on imports from 145% to 30%, while China dropped its import tariff from 125% to 10%. China said the US had "seriously undermined" the agreement. The comments come after US president Donald Trump said on Friday that China had "totally violated its agreement with us". Beijing said violations included the US blocking sales of computer chip design software to Chinese companies and warning against the use of Chinese computer chips made by companies such as Huawei. They also said the US had cancelled visas for Chinese students. London's premier index fell 0.3%, having opened higher. Defence contractor Babcock International (BAB.L) rose the most, as the UK announced plans to build up a fleet of 12 attack submarines. Germany's DAX (^GDAXI) fell slightly, while the CAC 40 (^FCHI) was 0.2% lower. The pan-European STOXX 600 (^STOXX) was down 0.1%. Last week, Europe agreed its own stay of execution in trade negotiations with the US, pushing back the implementation of a 50% import tariff to July while talks continue on a possible deal. Drug maker Indivior has announced plans to delist its shares from the London Stock Exchange (LSE), marking the latest company to abandon the UK market for the US. However, the LSE welcomes Anglo-American's platinum spin-off Valterra after becoming independent from the mining giant. Indivior's exit comes after the company moved its primary listing to the US's Nasdaq index last year. It said cancelling the secondary listing in London eliminates 'cost and complexity' and better reflects the business – with more than 80% of its revenues generated in the US. It also said liquidity on the Nasdaq now 'far outweighs' that of the LSE with a greater level of trading. The US-based pharmaceutical firm makes prescription medicines to treat opioid addiction, and has a market capitalisation of £1.2bn. 'A single primary listing on Nasdaq best reflects the profile of Indivior's business,' chairman David Wheadon said. Here's Pedro Goncalves full take on UK house prices: Views from the market: Jonathan Hopper, CEO of Garrington Property Finders, said: CEO of Yopa, Verona Frankish, said: Tony Redondo, founder at Cosmos Currency Exchange said: House price growth edged up in May, according to Nationwide. Here are the headlines from their report: Annual rate of house price growth increased marginally in May to 3.5%, compared to 3.4% in April House prices were up 0.5% month on month House prices in predominantly rural areas have risen by 23% over the last five years, compared to 18% in more urban areas The average price in May was £273,427, compared with £270,752 in April. Robert Gardner, Nationwide's chief economist, said: Asian stocks traded lower on Monday as trade tensions, again, escalate between the US and China. US stock futures edged lower Monday morning, as investors turned the page on a bullish May and eyed the month ahead with trade uncertainty lingering. S&P 500 futures (ES=F) were down 0.4%, as futures tied to the Dow Jones Industrial Average (YM=F) sank 0.5%. Contracts tied to the Nasdaq 100 (NQ=F) slipped 0.6%. The tepid start to June follows a standout May: The S&P 500 (^GSPC) rallied more than 6% in its best month since November 2023 and best May since 1990. The Nasdaq Composite (^IXIC) soared 9%, and the Dow (^DJI) notched a 4% gain. Tech stocks led the charge, as investor optimism around AI and resilient economic data fuelled risk appetite. Read more on Yahoo Finance Hello from London. Lucy Harley-McKeown here, ready to bring you the markets and business news of the day. We have a few diary items to start us off: PMI releases for the EU, UK and US Nationwide's house price index The monthly money and credit report from the Bank of England In the US, corporate results from Campbell Soup (CPB). Let's get to it. Drug maker Indivior has announced plans to delist its shares from the London Stock Exchange (LSE), marking the latest company to abandon the UK market for the US. However, the LSE welcomes Anglo-American's platinum spin-off Valterra after becoming independent from the mining giant. Indivior's exit comes after the company moved its primary listing to the US's Nasdaq index last year. It said cancelling the secondary listing in London eliminates 'cost and complexity' and better reflects the business – with more than 80% of its revenues generated in the US. It also said liquidity on the Nasdaq now 'far outweighs' that of the LSE with a greater level of trading. The US-based pharmaceutical firm makes prescription medicines to treat opioid addiction, and has a market capitalisation of £1.2bn. 'A single primary listing on Nasdaq best reflects the profile of Indivior's business,' chairman David Wheadon said. Here's Pedro Goncalves full take on UK house prices: Views from the market: Jonathan Hopper, CEO of Garrington Property Finders, said: CEO of Yopa, Verona Frankish, said: Tony Redondo, founder at Cosmos Currency Exchange said: House price growth edged up in May, according to Nationwide. Here are the headlines from their report: Annual rate of house price growth increased marginally in May to 3.5%, compared to 3.4% in April House prices were up 0.5% month on month House prices in predominantly rural areas have risen by 23% over the last five years, compared to 18% in more urban areas The average price in May was £273,427, compared with £270,752 in April. Robert Gardner, Nationwide's chief economist, said: Asian stocks traded lower on Monday as trade tensions, again, escalate between the US and China. US stock futures edged lower Monday morning, as investors turned the page on a bullish May and eyed the month ahead with trade uncertainty lingering. S&P 500 futures (ES=F) were down 0.4%, as futures tied to the Dow Jones Industrial Average (YM=F) sank 0.5%. Contracts tied to the Nasdaq 100 (NQ=F) slipped 0.6%. The tepid start to June follows a standout May: The S&P 500 (^GSPC) rallied more than 6% in its best month since November 2023 and best May since 1990. The Nasdaq Composite (^IXIC) soared 9%, and the Dow (^DJI) notched a 4% gain. Tech stocks led the charge, as investor optimism around AI and resilient economic data fuelled risk appetite. Read more on Yahoo Finance Hello from London. Lucy Harley-McKeown here, ready to bring you the markets and business news of the day. We have a few diary items to start us off: PMI releases for the EU, UK and US Nationwide's house price index The monthly money and credit report from the Bank of England In the US, corporate results from Campbell Soup (CPB). Let's get to it. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Newsweek
an hour ago
- Newsweek
China Accuses Trump of Violation, Threatens 'Forceful Measures'
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. China accused the U.S. of violating an agreement made at their tariff-cutting discussions in Geneva in May, and said it will take further action as the trade dispute between the world's two largest economies blows open again. President Donald Trump's administration has in recent days issued AI chip export control guidelines, stopped the sale of chip design software to China, and is planning to revoke a significant number of Chinese student visas. Trump had also accused the Chinese side of having "TOTALLY VIOLATED" the Geneva agreement, which saw the U.S. and China both reduce their import tariffs by 115 percentage points, soothing global markets. "These practices seriously violate the consensus" reached in Geneva, the Chinese Commerce Ministry said in a statement on Monday. The Commerce Ministry said China held up its end of the deal, canceling or suspending tariffs and non-tariff measures taken against the U.S. "reciprocal tariffs" following the agreement. "The United States has unilaterally provoked new economic and trade frictions, exacerbating the uncertainty and instability of bilateral economic and trade relations," while China has stood by its commitments, the statement said. It also threatened unspecified retaliation, saying China will "continue to take resolute and forceful measures to safeguard its legitimate rights and interests." And in response to recent comments by Trump, it said of the U.S.: "Instead of reflecting on itself, it has turned the tables and unreasonably accused China of violating the consensus, which is seriously contrary to the facts." This is a developing article. Updates to follow. This article includes reporting by The Associated Press.
Yahoo
an hour ago
- Yahoo
Who is Poland's next president Karol Nawrocki?
By Anna Wlodarczak-Semczuk and Justyna Pawlak WARSAW (Reuters) -Karol Nawrocki, the conservative historian who won Poland's presidential election, cultivated a tough-guy image during his campaign, posting videos of himself at shooting ranges and boxing rings. While his liberal opponent Rafal Trzaskowski played up his European credentials, Nawrocki met Donald Trump at the White House and received the U.S. president's backing for his bid for Poland's top job. According to the final result from the electoral commission, Nawrocki won the election with 50.89% of the votes. Unlike other eurosceptics in central Europe, such as Slovak Prime Minister Robert Fico or Hungary's Viktor Orban, Nawrocki supports giving military aid to help Ukraine fend off Russia's three-year-old invasion. But he has said that, if elected, he will oppose membership in Western alliances for Ukraine, a position that seeks to chime with falling support for Ukrainians among Poles, who have hosted more than a million refugees from across the border. His backers in the Law and Justice (PiS) party had supported fast-tracking membership in the EU and NATO for Kyiv while in power until late 2023. Nawrocki's critics said he was fuelling unease over Ukrainian refugees at a time when the far-right is highlighting migration, the cost of living and security. He cited his campaign slogan, Poland First. "Let's help others, but let's take care of our own citizens first," he said on social media in April. He is likely to follow a similar path to outgoing President Andrzej Duda, a PiS ally who has used his veto power to block the pro-EU government's efforts to undo the previous PiS administration's judicial reforms. The EU says the PiS reforms undermined the independence of the courts. THE FIGHT IN THE RIGHT In the last two weeks, the candidates mostly fought for the support of people who voted for other candidates in the first round, in particular far-right's Slawomir Mentzen who came third with 15% support. Trzaskowski tried to attract them with promises of deregulation. Nawrocki touted his credentials as head of the Institute of National Remembrance (IPN), support for gun ownership, traditional families and Christian values, but also a critical tone on Ukraine, in sync with Mentzen's. His wife Marta, a civil servant, and three children featured strongly in his campaign. Nawrocki's past has been a topic of intense public debate following a series of negative media reports. There were questions over his acquisition of a flat from a pensioner and an admission that he took part in orchestrated brawls. "All my sports activities were based on the strength of my heart, the strength of my muscles, my fists," Nawrocki, an amateur boxer, told a debate when confronted over reports he had been involved in mass organised fights between football hooligans. "It was a fair competition, regardless of the form." His Law and Justice party backers have accused the government of orchestrating the controversies with the help of Poland's special services and liberal media. The government rejects these accusations. Nawrocki portrayed the election as a referendum on the government, which he described as a metropolitan elite out of touch with their concerns. "I am simply one of you," he told voters in the eastern town of Biala Podlaska while on the campaign trail.
